Immunogenic Tumor Cell Death for Optimal Anticancer Therapy: The Calreticulin Exposure Pathway
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-09-2891
Full Text
Open PDFAbstract
Available in full text
Date
April 26, 2010
Authors
Publisher
American Association for Cancer Research (AACR)